CN115260136B - Phthalide compound and preparation method thereof - Google Patents
Phthalide compound and preparation method thereof Download PDFInfo
- Publication number
- CN115260136B CN115260136B CN202210950641.8A CN202210950641A CN115260136B CN 115260136 B CN115260136 B CN 115260136B CN 202210950641 A CN202210950641 A CN 202210950641A CN 115260136 B CN115260136 B CN 115260136B
- Authority
- CN
- China
- Prior art keywords
- synthesis reaction
- preparation
- group
- methoxybenzamide
- phthalide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- WNZQDUSMALZDQF-UHFFFAOYSA-N isobenzofuranone Natural products C1=CC=C2C(=O)OCC2=C1 WNZQDUSMALZDQF-UHFFFAOYSA-N 0.000 title claims abstract description 28
- -1 Phthalide compound Chemical class 0.000 title claims abstract description 21
- 238000002360 preparation method Methods 0.000 title claims abstract description 15
- 238000006243 chemical reaction Methods 0.000 claims abstract description 37
- 238000003786 synthesis reaction Methods 0.000 claims abstract description 33
- PBQZQTQFQFYBNJ-UHFFFAOYSA-N n-methoxybenzamide Chemical compound CONC(=O)C1=CC=CC=C1 PBQZQTQFQFYBNJ-UHFFFAOYSA-N 0.000 claims abstract description 14
- 239000003054 catalyst Substances 0.000 claims abstract description 12
- 239000003960 organic solvent Substances 0.000 claims abstract description 7
- 125000005843 halogen group Chemical group 0.000 claims abstract description 6
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 5
- 125000003118 aryl group Chemical group 0.000 claims abstract description 5
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims abstract description 5
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims abstract description 4
- 239000001257 hydrogen Substances 0.000 claims abstract description 4
- 229910052739 hydrogen Inorganic materials 0.000 claims abstract description 4
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims abstract description 4
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 45
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 24
- 229960002089 ferrous chloride Drugs 0.000 claims description 15
- NMCUIPGRVMDVDB-UHFFFAOYSA-L iron dichloride Chemical compound Cl[Fe]Cl NMCUIPGRVMDVDB-UHFFFAOYSA-L 0.000 claims description 15
- 238000004440 column chromatography Methods 0.000 claims description 14
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 claims description 13
- 239000000706 filtrate Substances 0.000 claims description 13
- 229910052757 nitrogen Inorganic materials 0.000 claims description 12
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 6
- WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 claims description 3
- SQGNQVYHTWMVMV-UHFFFAOYSA-N 2-ethyl-N-methoxybenzamide Chemical compound CCC1=CC=CC=C1C(=O)NOC SQGNQVYHTWMVMV-UHFFFAOYSA-N 0.000 claims description 3
- XJVDIMLQFRPIMP-UHFFFAOYSA-N 3-methyl-3h-2-benzofuran-1-one Chemical compound C1=CC=C2C(C)OC(=O)C2=C1 XJVDIMLQFRPIMP-UHFFFAOYSA-N 0.000 claims description 3
- 229910021578 Iron(III) chloride Inorganic materials 0.000 claims description 3
- RBTARNINKXHZNM-UHFFFAOYSA-K iron trichloride Chemical compound Cl[Fe](Cl)Cl RBTARNINKXHZNM-UHFFFAOYSA-K 0.000 claims description 3
- HUIINBQKOSVJRH-UHFFFAOYSA-N n-methoxy-2-methylbenzamide Chemical compound CONC(=O)C1=CC=CC=C1C HUIINBQKOSVJRH-UHFFFAOYSA-N 0.000 claims description 3
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims description 3
- JHUUPUMBZGWODW-UHFFFAOYSA-N 3,6-dihydro-1,2-dioxine Chemical compound C1OOCC=C1 JHUUPUMBZGWODW-UHFFFAOYSA-N 0.000 claims 2
- 238000000034 method Methods 0.000 abstract description 17
- 230000035484 reaction time Effects 0.000 abstract description 5
- 125000005506 phthalide group Chemical class 0.000 abstract description 4
- 239000002994 raw material Substances 0.000 abstract description 4
- 239000000758 substrate Substances 0.000 abstract description 4
- 239000010970 precious metal Substances 0.000 abstract description 2
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 32
- 238000005160 1H NMR spectroscopy Methods 0.000 description 8
- 238000002955 isolation Methods 0.000 description 7
- 238000004983 proton decoupled 13C NMR spectroscopy Methods 0.000 description 6
- 238000000926 separation method Methods 0.000 description 4
- 238000002156 mixing Methods 0.000 description 3
- 229910000510 noble metal Inorganic materials 0.000 description 3
- 238000004009 13C{1H}-NMR spectroscopy Methods 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 230000000259 anti-tumor effect Effects 0.000 description 2
- BEGXNOKEKMOQMO-UHFFFAOYSA-N benzamido 2,2-dimethylpropanoate Chemical compound CC(C)(C)C(=O)ONC(=O)C1=CC=CC=C1 BEGXNOKEKMOQMO-UHFFFAOYSA-N 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 239000012295 chemical reaction liquid Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- KEEBHMMBUBEEOV-UHFFFAOYSA-N n-(4-methoxyphenyl)benzamide Chemical compound C1=CC(OC)=CC=C1NC(=O)C1=CC=CC=C1 KEEBHMMBUBEEOV-UHFFFAOYSA-N 0.000 description 2
- UVSMNLNDYGZFPF-UHFFFAOYSA-N pomalidomide Chemical compound O=C1C=2C(N)=CC=CC=2C(=O)N1C1CCC(=O)NC1=O UVSMNLNDYGZFPF-UHFFFAOYSA-N 0.000 description 2
- SIZYBXMKRRSTEM-UHFFFAOYSA-N 2-benzyl-n-methoxybenzamide Chemical compound CONC(=O)C1=CC=CC=C1CC1=CC=CC=C1 SIZYBXMKRRSTEM-UHFFFAOYSA-N 0.000 description 1
- SQFMIHCARVMICF-UHFFFAOYSA-N 3-phenyl-3h-2-benzofuran-1-one Chemical compound C12=CC=CC=C2C(=O)OC1C1=CC=CC=C1 SQFMIHCARVMICF-UHFFFAOYSA-N 0.000 description 1
- UKFAWRZYFYOXEG-UHFFFAOYSA-N 5,6-dimethoxy-3H-isobenzofuran-1-one Chemical compound C1=C(OC)C(OC)=CC2=C1C(=O)OC2 UKFAWRZYFYOXEG-UHFFFAOYSA-N 0.000 description 1
- UPHMIATWSMZUFS-UHFFFAOYSA-N COC1=CC=C2C(C)OC(=O)C2=C1 Chemical compound COC1=CC=C2C(C)OC(=O)C2=C1 UPHMIATWSMZUFS-UHFFFAOYSA-N 0.000 description 1
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 125000001584 benzyloxycarbonyl group Chemical group C(=O)(OCC1=CC=CC=C1)* 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 229910001882 dioxygen Inorganic materials 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 150000002391 heterocyclic compounds Chemical class 0.000 description 1
- 239000000543 intermediate Substances 0.000 description 1
- 238000007273 lactonization reaction Methods 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- 229960000688 pomalidomide Drugs 0.000 description 1
- 229940008606 pomalyst Drugs 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 238000010189 synthetic method Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/87—Benzo [c] furans; Hydrogenated benzo [c] furans
- C07D307/88—Benzo [c] furans; Hydrogenated benzo [c] furans with one oxygen atom directly attached in position 1 or 3
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Abstract
本发明提供一种苯酞类化合物及其制备方法,具有式I所示结构:其中,R1为‑H、卤素基团、甲氧基或甲基;R2为芳基、烷基或氢。将N‑甲氧基苯甲酰胺、催化剂和有机溶剂混合,进行合成反应,合成反应的温度为70‑80℃,合成反应的时间为10‑12h,得到苯酞类化合物,本发明提供的制备方法不使用贵金属,所需反应时间更短,反应条件温和;以N‑甲氧基苯甲酰胺作为原料,一步合成苯酞类化合物,方法简洁、快速、底物适用性广。
The present invention provides a kind of phthalide compound and preparation method thereof, have the structure shown in formula I: Wherein, R1 is -H, a halogen group, a methoxy group or a methyl group; R2 is an aryl group, an alkyl group or hydrogen. Mix N-methoxybenzamide, a catalyst and an organic solvent to carry out a synthesis reaction. The temperature of the synthesis reaction is 70-80° C., and the time of the synthesis reaction is 10-12 hours to obtain phthalide compounds. The preparation provided by the invention The method does not use precious metals, the required reaction time is shorter, and the reaction conditions are mild; N-methoxybenzamide is used as a raw material to synthesize phthalides in one step. The method is simple, fast, and has wide substrate applicability.
Description
技术领域technical field
本发明涉及有机合成技术领域,尤其涉及一种苯酞类化合物及其制备方法。The invention relates to the technical field of organic synthesis, in particular to a phthalide compound and a preparation method thereof.
背景技术Background technique
苯酞是存在于自然界的一类重要杂环化合物,许多药物或药物中间体中均含有苯酞单元。越来越多的研究表明:苯酞类衍生物具有解热、镇痛、抗肿瘤和抗细菌真菌等药理活性。如:泊马度胺(Pomalyst)具有很好的抗肿瘤活性。Phthalide is an important class of heterocyclic compounds existing in nature, and many drugs or drug intermediates contain phthalide units. More and more studies have shown that phthalide derivatives have pharmacological activities such as antipyretic, analgesic, antitumor and antibacterial fungi. Such as: pomalidomide (Pomalyst) has very good antitumor activity.
2020年,余金权小组报道了以邻甲基苯甲酸为原料,利用Pd催化的反应合成了苯酞类化合物(Ligand-EnabledPd(II)-Catalyzed C(sp3)–H Lactonization UsingMolecular Oxygen as Oxidant.Org.Lett.2020,22,3960-3963)。该反应虽然高效,但是原料的合成催化剂成本较高、反应条件高、反应时间较长,基于上述因素特别研发了一种苯酞类化合物及其制备方法,相对于传统的贵金属法具有成本优势,且反应时间短,简洁高效、反应条件温和。In 2020, Yu Jinquan's group reported the synthesis of phthalides (Ligand-EnabledPd(II)-Catalyzed C(sp3)–H Lactonization Using Molecular Oxygen as Oxidant.Org. Lett. 2020, 22, 3960-3963). Although the reaction is efficient, the cost of the raw material synthesis catalyst is high, the reaction conditions are high, and the reaction time is long. Based on the above factors, a phthalide compound and its preparation method have been specially developed, which has a cost advantage compared with the traditional precious metal method. Moreover, the reaction time is short, simple and efficient, and the reaction conditions are mild.
发明内容Contents of the invention
本本发明的目的在于提供一种苯酞类化合物及其制备方法,其制备方法相对于传统的贵金属法具有成本优势,该方法一步合成苯酞类化合物,方法简洁、快速、底物适用性广。The object of the present invention is to provide a kind of phthalide compound and its preparation method, and its preparation method has cost advantage compared with traditional noble metal method, and this method synthesizes phthalide compound in one step, and method is simple, fast, and substrate applicability is wide.
本发明的目的是通过下述技术方案予以实现:一种苯酞类化合物,具有式I所示结构:The object of the present invention is to be realized by the following technical scheme: a kind of phthalide compound has the structure shown in formula I:
其中,R1为-H、卤素基团、甲氧基或甲基;R2为芳基、烷基或氢。Wherein, R1 is -H, halogen group, methoxy group or methyl group; R2 is aryl group, alkyl group or hydrogen.
进一步地,所述卤素基团包括-F、-Cl或-Br。Further, the halogen group includes -F, -Cl or -Br.
进一步地,苯酞类化合物的制备方法,包括以下步骤:Further, the preparation method of phthalide compound comprises the following steps:
将N-苯甲酰胺、催化剂、甲醇与有机溶剂混合,进行合成反应,合成反应的温度为70-80℃,合成反应的时间为10-12h,得到苯酞类化合物;Mix N-benzamide, catalyst, methanol and organic solvent to carry out a synthesis reaction, the temperature of the synthesis reaction is 70-80°C, and the time of the synthesis reaction is 10-12h, to obtain phthalide compounds;
所述N-甲氧基苯甲酰胺有式II所示结构;The N-methoxybenzamide has a structure shown in formula II;
所述N-苯甲酰胺优选包括、N-甲氧基苯甲酰胺、N-(4-甲氧基苯基)苯甲酰胺、N-新戊酰氧基苯甲酰胺中的一种。The N-benzamide preferably includes one of N-methoxybenzamide, N-(4-methoxyphenyl)benzamide, and N-pivaloyloxybenzamide.
进一步地,具体地:将N-甲氧基-2乙基-苯甲酰胺、氯化亚铁及甲醇加入到1,4二氧六环中混合,将所得反应溶液在氮气与光照条件下加热到70℃,进行合成反应12h,将所得反应液过滤,将所得滤液柱层析分离,得到:3-甲基异苯并呋喃-1(3H)-酮,分离收率为80%,合成反应方程式如下:Further, specifically: N-methoxy-2 ethyl-benzamide, ferrous chloride and methanol are added to 1,4-dioxane and mixed, and the resulting reaction solution is heated under nitrogen and light conditions to 70°C, carry out the synthesis reaction for 12 hours, filter the resulting reaction solution, and separate the resulting filtrate by column chromatography to obtain: 3-methylisobenzofuran-1(3H)-one, the separation yield is 80%, the synthesis reaction The equation is as follows:
进一步地,具体地:将N-甲氧基-2甲基-苯甲酰胺、氯化亚铁及甲醇加入到1,4二氧六环中混合,将所得反应溶液在氮气与光照条件下加热到70℃,进行合成反应10h,将所得反应液过滤,将所得滤液柱层析分离,得到异苯并呋喃-1(3H)-酮,分离收率为75%,合成反应方程式如下:Further, specifically: N-methoxy-2methyl-benzamide, ferrous chloride and methanol are added to 1,4-dioxane and mixed, and the resulting reaction solution is heated under nitrogen and light conditions to 70°C, carry out the synthesis reaction for 10 h, filter the obtained reaction liquid, and separate the obtained filtrate by column chromatography to obtain isobenzofuran-1(3H)-one, the separation yield is 75%, and the synthesis reaction equation is as follows:
进一步地,所述N-甲氧基苯甲酰胺、催化剂的摩尔比为1:0.2-0.4。Further, the molar ratio of the N-methoxybenzamide to the catalyst is 1:0.2-0.4.
进一步地,所述催化剂为氯化亚铁或氯化铁;所述催化剂的摩尔百分比为20-40%。Further, the catalyst is ferrous chloride or ferric chloride; the molar percentage of the catalyst is 20-40%.
进一步地,所述有机溶剂包括1,2-二氯乙烷、1.4-二氧六环或四氢呋喃。Further, the organic solvent includes 1,2-dichloroethane, 1.4-dioxane or tetrahydrofuran.
与现有技术相比,本发明的有益效果是:Compared with prior art, the beneficial effect of the present invention is:
本发明提供了苯酞类化合物的制备方法,该方法不使用贵金属,反应条件简单,且反应条件温和,反应时间更短。The invention provides a preparation method of phthalide compounds. The method does not use noble metals, has simple and mild reaction conditions and shorter reaction time.
本发明方法以简单易得的N-甲氧基苯甲酰胺为原料,一步合成苯酞类化合物,方法简洁、快速、底物适用性广。The method of the invention uses the simple and easy-to-obtain N-methoxybenzamide as a raw material to synthesize phthalide compounds in one step, and the method is simple and fast, and the substrate has wide applicability.
附图说明Description of drawings
图1为4-苯酞类化合物结构示意图;Fig. 1 is a schematic diagram of the structure of 4-phthalide compounds;
图2为合成反应方程式。Figure 2 is the synthesis reaction equation.
具体实施方式Detailed ways
下面将结合本发明实施例中的附图,对本发明实施例中的技术方案进行清楚、完整地描述,显然,所描述的实施例仅仅是本发明一部分实施例,而不是全部的实施例,基于本发明中的实施例,本领域普通技术人员在没有做出创造性劳动前提下所获得的所有其他实施例,都属于本发明保护的范围。The technical solutions in the embodiments of the present invention will be clearly and completely described below in conjunction with the accompanying drawings in the embodiments of the present invention. Obviously, the described embodiments are only some of the embodiments of the present invention, not all of them. Based on The embodiments of the present invention and all other embodiments obtained by persons of ordinary skill in the art without making creative efforts belong to the protection scope of the present invention.
结合图1-2具体对本发明做进一步阐述,本发明提供了一种苯酞类化合物,具有式I所示结构:The present invention is further elaborated in conjunction with Fig. 1-2, the present invention provides a kind of phthalide compound, has the structure shown in formula I:
其中,R1为-H、卤素基团、甲氧基或甲基;R2为芳基、烷基或氢。在本发明中,所述卤素基团优选包括-F、-Cl或-Br;在本发明中,Wherein, R1 is -H, halogen group, methoxy group or methyl group; R2 is aryl group, alkyl group or hydrogen. In the present invention, the halogen group preferably includes -F, -Cl or -Br; in the present invention,
所述芳基优选为苯基,所述烷基优选为甲基、乙基。The aryl group is preferably a phenyl group, and the alkyl group is preferably a methyl group or an ethyl group.
本发明提供了上述技术方案所述的苯酞类化合物的合成方法,包括以下步骤:The present invention provides the synthetic method of the phthalide compound described in above-mentioned technical scheme, comprises the following steps:
将N-甲氧基苯甲酰胺、催化剂和额外添加的甲醇及有机溶剂混合,在光照下进行合成反应,得到苯酞类化合物;Mixing N-methoxybenzamide, a catalyst, additionally added methanol and an organic solvent, and performing a synthesis reaction under light to obtain phthalide compounds;
所述N-甲氧基苯甲酰胺具有式II所示结构;The N-methoxybenzamide has a structure shown in formula II;
在本发明中,所述N-苯甲酰胺优选包括、N-甲氧基苯甲酰胺、N-(4-甲氧基苯基)苯甲酰胺、N-新戊酰氧基苯甲酰胺。In the present invention, the N-benzamide preferably includes N-methoxybenzamide, N-(4-methoxyphenyl)benzamide, and N-pivaloyloxybenzamide.
在本发明中,所述催化剂优选为氯化亚铁、氯化铁;In the present invention, the catalyst is preferably ferrous chloride, ferric chloride;
所述N-甲氧基苯甲酰胺与催化剂的摩尔百分比优选为20-40%,更优选为30-40%。The molar percentage of the N-methoxybenzamide and the catalyst is preferably 20-40%, more preferably 30-40%.
在本发明中,所述有机溶剂优选包括1,2-二氯乙烷、1,4二氧六环或四氢呋喃。In the present invention, the organic solvent preferably includes 1,2-dichloroethane, 1,4-dioxane or tetrahydrofuran.
本发明对所述混合的过程没有特殊的限定,选用本领域技术人员熟知的混合过程即可。The present invention has no special limitation on the mixing process, and the mixing process well known to those skilled in the art can be selected.
在本发明中,所述合成反应的温度为70-80℃,所述合成反应的时间为10-12h。完成所述合成反应后,本发明优选将所得反应液过滤,然后将所得滤液进行柱层析分离,得到苯酞类化合物。In the present invention, the temperature of the synthesis reaction is 70-80° C., and the time of the synthesis reaction is 10-12 hours. After the synthesis reaction is completed, the present invention preferably filters the obtained reaction liquid, and then separates the obtained filtrate by column chromatography to obtain phthalide compounds.
本发明对所述过滤和柱层析分离的具体方式和条件没有特殊的限定,选用本领域技术人员熟知的方式和条件即可。The present invention has no special limitations on the specific methods and conditions of the filtration and column chromatography separation, and the methods and conditions well-known to those skilled in the art can be selected.
下面结合实施例对本发明提供的苯酞类化合物及其制备方法进行详细的说明,但是不能把它们理解为对本发明保护范围的限定。The phthalide compounds provided by the present invention and their preparation methods are described in detail below in conjunction with the examples, but they cannot be interpreted as limiting the protection scope of the present invention.
实施例1Example 1
将N-甲氧基-2甲基-苯甲酰胺(1a,0.10M)、氯化亚铁(40mol%)及甲醇(1eq,0.10M)加入到1,4二氧六环中混合,将所得反应溶液在氮气与光照条件下加热到70℃,进行合成反应10h,将所得反应液过滤,将所得滤液柱层析分离,得到异苯并呋喃-1(3H)-酮(4a)。分离收率为75%;实施例1的合成反应方程式如下:N-methoxy-2methyl-benzamide (1a, 0.10M), ferrous chloride (40mol%) and methanol (1eq, 0.10M) were added to 1,4 dioxane and mixed. The obtained reaction solution was heated to 70° C. under nitrogen and light conditions, and the synthesis reaction was carried out for 10 h. The obtained reaction solution was filtered, and the obtained filtrate was separated by column chromatography to obtain isobenzofuran-1(3H)-one (4a). Isolation yield is 75%; The synthetic reaction equation of embodiment 1 is as follows:
1H NMR(400MHz,CDCl3)δ7.91–7.89(m,1H),7.69–7.65(m,1H),7.54–7.48(m,2H),5.31(s,2H).13C{1H}NMR(100MHz,CDCl3)δ170.7,146.5,134.0,125.7,125.7,122.0,69.7;HRMS(ESI-TOF):([M+H]+)calcd for C8H7O2+:135.0446;found:135.0445。1H NMR (400MHz, CDCl3) δ7.91–7.89(m,1H),7.69–7.65(m,1H),7.54–7.48(m,2H),5.31(s,2H).13C{1H}NMR(100MHz , CDCl3) δ170.7, 146.5, 134.0, 125.7, 125.7, 122.0, 69.7; HRMS (ESI-TOF): ([M+H]+) calcd for C8H7O2+: 135.0446; found: 135.0445.
实施例2Example 2
将N-甲氧基-2乙基-苯甲酰胺(1b,0.10M)、氯化亚铁(40mol%)及甲醇(1eq,0.10M)加入到1,4二氧六环中混合,将所得反应溶液在氮气与光照条件下加热到70℃,进行合成反应10h,将所得反应液过滤,将所得滤液柱层析分离,得到:3-甲基异苯并呋喃-1(3H)-酮(4b)。分离收率为80%;实施例2的合成反应方程式如下:N-methoxy-2 ethyl-benzamide (1b, 0.10M), ferrous chloride (40mol%) and methanol (1eq, 0.10M) were added to 1,4 dioxane and mixed. The obtained reaction solution was heated to 70° C. under nitrogen and light conditions, and the synthesis reaction was carried out for 10 hours. The obtained reaction solution was filtered, and the obtained filtrate was separated by column chromatography to obtain: 3-methylisobenzofuran-1(3H)-one (4b). The separation yield is 80%; the synthetic reaction equation of embodiment 2 is as follows:
1H NMR(400MHz,CDCl3)δ7.77–7.75(m,1H),7.62–7.58(m,1H),7.45–7.38(m,2H),5.49(q,J=6.3Hz,1H),1.54(d,J=6.7Hz,3H).13C{1H}NMR(100MHz,CDCl3)δ170.5,151.2,134.1,129.0,125.5,125.4,121.7,77.8,20.3;IR(NaCl);HRMS(ESI-TOF):([M+H]+)calcdforC10H11O2+:149.0603;found:149.0609。1H NMR (400MHz, CDCl3) δ7.77–7.75(m,1H),7.62–7.58(m,1H),7.45–7.38(m,2H),5.49(q,J=6.3Hz,1H),1.54( d, J=6.7Hz, 3H).13C{1H}NMR (100MHz, CDCl3) δ170.5, 151.2, 134.1, 129.0, 125.5, 125.4, 121.7, 77.8, 20.3; IR (NaCl); HRMS (ESI-TOF): ([M+H]+) calcd for C10H11O2+: 149.0603; found: 149.0609.
实施例3Example 3
将2-苄基-N-甲氧基苯甲酰胺(1c,0.10M)、氯化亚铁(40mol%)及甲醇(1eq,0.10M)加入到1,4二氧六环中混合,将所得反应溶液在氮气与光照条件下加热到70℃,进行合成反应10h,将所得反应液过滤,将所得滤液柱层析分离,得到3-苯基异苯并呋喃-1(3H)-酮(4a)。分离收率为68%;实施例3的合成反应方程式如下:2-benzyl-N-methoxybenzamide (1c, 0.10M), ferrous chloride (40mol%) and methanol (1eq, 0.10M) were added to 1,4 dioxane and mixed. The obtained reaction solution was heated to 70° C. under nitrogen and light conditions, and the synthesis reaction was carried out for 10 h. The obtained reaction solution was filtered, and the obtained filtrate was separated by column chromatography to obtain 3-phenylisobenzofuran-1(3H)-one ( 4a). Isolation yield is 68%; The synthetic reaction equation of embodiment 3 is as follows:
1H NMR(400MHz,CDCl3)δ7.99–7.94(m,1H),7.66–7.62(m,1H),7.58–7.53(m,1H),7.42–7.23(m,7H),6.40(s,1H);13C{1H}NMR(100MHz,CDCl3)δ170.6,149.7,136.4,134.3,129.4,129.3,129.0,127.0,125.7,125.56,122.9,82.7;HRMS(ESI-TOF):([M+H]+)calcdfor C14H11O2+:211.0759;found:211.0756。1H NMR (400MHz, CDCl3) δ7.99–7.94(m,1H),7.66–7.62(m,1H),7.58–7.53(m,1H),7.42–7.23(m,7H),6.40(s,1H ); 13C{1H}NMR (100MHz, CDCl3) δ170.6, 149.7, 136.4, 134.3, 129.4, 129.3, 129.0, 127.0, 125.7, 125.56, 122.9, 82.7; HRMS (ESI-TOF): ([M+H]+ ) calcd for C14H11O2+: 211.0759; found: 211.0756.
实施例4Example 4
将2-乙基-N,5-二甲氧基苯甲酰胺(1d,0.10M)、氯化亚铁(40mol%)及甲醇(1eq,0.10M)加入到1,4二氧六环中混合,将所得反应溶液在氮气与光照条件下加热到70℃,进行合成反应10h,将所得反应液过滤,将所得滤液柱层析分离,得到6-甲氧基-3甲基异苯并呋喃-1(3H)-酮(4d)。分离收率为61%;实施例4的合成反应方程式如下:Add 2-ethyl-N,5-dimethoxybenzamide (1d, 0.10M), ferrous chloride (40mol%) and methanol (1eq, 0.10M) to 1,4-dioxane Mix, heat the obtained reaction solution to 70°C under nitrogen and light conditions, carry out the synthesis reaction for 10 hours, filter the obtained reaction solution, and separate the obtained filtrate by column chromatography to obtain 6-methoxy-3-methylisobenzofuran -1(3H)-one (4d). Isolation yield is 61%; The synthetic reaction equation of embodiment 4 is as follows:
1H NMR(400MHz,CDCl3)δ7.30–7.25(m,2H),7.21–7.19(m,1H),5.49(q,J=6.6Hz,1H),3.83(s,3H),1.57(d,J=6.6Hz,3H).13C{1H}NMR(100MHz,CDCl3)δ170.7,170.5,160.6,143.7,123.0,122.4,107.4,77.7,55.8,20.5;HRMS(ESI-TOF):([M+H]+)calcd forC10H11O3+:179.0708;found:179.0713。1H NMR (400MHz, CDCl3) δ7.30–7.25(m,2H),7.21–7.19(m,1H),5.49(q,J=6.6Hz,1H),3.83(s,3H),1.57(d, J=6.6Hz,3H).13C{1H}NMR(100MHz,CDCl3)δ170.7,170.5,160.6,143.7,123.0,122.4,107.4,77.7,55.8,20.5; HRMS(ESI-TOF):([M+H ]+) calcd for C10H11O3+: 179.0708; found: 179.0713.
实施例5Example 5
将5-氯-2-乙基-N-甲氧基苯甲酰胺(1e,0.10M)、氯化亚铁(40mol%)及甲醇(1eq,0.10M)加入到1,4二氧六环中混合,将所得反应溶液在氮气与光照条件下加热到70℃,进行合成反应10h,将所得反应液过滤,将所得滤液柱层析分离,得到6-氯-3-甲基异苯并呋喃-1(3H)-酮(4e)。分离收率为61%;实施例5的合成反应方程式如下:Add 5-chloro-2-ethyl-N-methoxybenzamide (1e, 0.10M), ferrous chloride (40mol%) and methanol (1eq, 0.10M) to 1,4-dioxane mixed in , the resulting reaction solution was heated to 70°C under nitrogen and light conditions, and the synthesis reaction was carried out for 10 hours, the resulting reaction solution was filtered, and the resulting filtrate was separated by column chromatography to obtain 6-chloro-3-methylisobenzofuran -1(3H)-one (4e). Isolation yield is 61%; The synthetic reaction equation of embodiment 5 is as follows:
1H NMR(400MHz,CDCl3)δ7.82(s,1H),7.62–7.60(m,1H),7.37–7.35(m,1H),5.53(q,J=6.6Hz,6.1Hz,1H),1.60(d,J=5.8Hz,3H).13C{1H}NMR(100MHz,CDCl3)δ168.9,149.3,135.4,134.3,127.6,125.6,122.9,77.6,20.3;HRMS(ESI-TOF):([M+H]+)calcd forC9H8ClO2+:183.0213;found:183.0218。1H NMR (400MHz, CDCl3) δ7.82(s,1H),7.62–7.60(m,1H),7.37–7.35(m,1H),5.53(q,J=6.6Hz,6.1Hz,1H),1.60 (d, J=5.8Hz, 3H).13C{1H}NMR (100MHz, CDCl3) δ168.9, 149.3, 135.4, 134.3, 127.6, 125.6, 122.9, 77.6, 20.3; HRMS (ESI-TOF): ([M+ H]+) calcd for C9H8ClO2+: 183.0213; found: 183.0218.
实施例6Example 6
将2-甲基-N,4,5-三甲氧基苯甲酰胺(1f,0.10M)、氯化亚铁(40mol%)及甲醇(1eq,0.10M)加入到1,4二氧六环中混合,将所得反应溶液在氮气与光照条件下加热到70℃,进行合成反应10h,将所得反应液过滤,将所得滤液柱层析分离,得到5,6-二甲氧基异苯并呋喃-1(3H)-酮(4f)。分离收率为61%;实施例6的合成反应方程式如下:2-Methyl-N,4,5-trimethoxybenzamide (1f, 0.10M), ferrous chloride (40mol%) and methanol (1eq, 0.10M) were added to 1,4 dioxane Mixed in , the resulting reaction solution was heated to 70 ° C under nitrogen and light conditions, the synthesis reaction was carried out for 10 hours, the resulting reaction solution was filtered, and the resulting filtrate was separated by column chromatography to obtain 5,6-dimethoxyisobenzofuran -1(3H)-one (4f). Isolation yield is 61%; The synthetic reaction equation of embodiment 6 is as follows:
1H NMR(400MHz,CDCl3)δ7.29(s,1H),6.89(s,1H),5.20(s,2H),3.96(s,3H),3.92(s,3H).13C{1H}NMR(100MHz,CDCl3)δ171.5,154.9,150.4,141.0,117.6,106.1,103.4,69.1,56.4,56.3;HRMS(ESI-TOF):([M+H]+)calcdforC10H11O4+:195.0657;found:195.0665。1H NMR (400MHz, CDCl3) δ7.29(s,1H),6.89(s,1H),5.20(s,2H),3.96(s,3H),3.92(s,3H).13C{1H}NMR( 100MHz, CDCl3) δ171.5, 154.9, 150.4, 141.0, 117.6, 106.1, 103.4, 69.1, 56.4, 56.3; HRMS (ESI-TOF): ([M+H]+) calcdforC10H11O4+: 195.0657; found: 195.0665.
实施例7Example 7
将5-溴-N-甲氧基-2-甲基苯甲酰胺(1g,0.10M)、氯化亚铁(40mol%)及甲醇(1eq,0.10M)加入到1,4二氧六环中混合,将所得反应溶液在氮气与光照条件下加热到70℃,进行合成反应10h,将所得反应液过滤,将所得滤液柱层析分离,得到6-溴异苯并呋喃-1(3H)-酮(4g)。分离收率为61%;实施例7的合成反应方程式如下:5-Bromo-N-methoxy-2-methylbenzamide (1g, 0.10M), ferrous chloride (40mol%) and methanol (1eq, 0.10M) were added to 1,4-dioxane mixed in , the resulting reaction solution was heated to 70°C under nitrogen and light conditions, and the synthesis reaction was carried out for 10 hours. The resulting reaction solution was filtered, and the resulting filtrate was separated by column chromatography to obtain 6-bromoisobenzofuran-1(3H) - Ketones (4 g). Isolation yield is 61%; The synthetic reaction equation of embodiment 7 is as follows:
1H NMR(400MHz,CDCl3)δ8.03(s,1H),7.79(d,J=8.0Hz,1H),7.38(d,J=8.0Hz,1H),5.27(s,2H).13C{1H}NMR(100MHz,CDCl3)δ169.5,145.1,137.1,128.8,127.8,123.7,123.0,69.5;HRMS(ESI-TOF):([M+H]+)calcd for C8H6BrO2+:212.9551;found:212.9557。1H NMR (400MHz, CDCl3) δ8.03(s,1H),7.79(d,J=8.0Hz,1H),7.38(d,J=8.0Hz,1H),5.27(s,2H).13C{1H }NMR (100MHz, CDCl3) δ169.5, 145.1, 137.1, 128.8, 127.8, 123.7, 123.0, 69.5; HRMS (ESI-TOF): ([M+H]+) calcd for C8H6BrO2+: 212.9551; found: 212.9557.
实施例8Example 8
将N-甲氧基-2-戊基苯甲酰胺(1h,0.10M)、氯化亚铁(40mol%)及甲醇(1eq,0.10M)加入到1,4二氧六环中混合,将所得反应溶液在氮气与光照条件下加热到70℃,进行合成反应10h,将所得反应液过滤,将所得滤液柱层析分离,得到3-丁苯并呋喃-1(3H)-酮(4h)。分离收率为61%;实施例8的合成反应方程式如下:N-methoxy-2-pentylbenzamide (1h, 0.10M), ferrous chloride (40mol%) and methanol (1eq, 0.10M) were added to 1,4 dioxane and mixed. The obtained reaction solution was heated to 70° C. under nitrogen and light conditions, and the synthesis reaction was carried out for 10 hours. The obtained reaction solution was filtered, and the obtained filtrate was separated by column chromatography to obtain 3-butylbenzofuran-1(3H)-one (4h) . Isolation yield is 61%; The synthetic reaction equation of embodiment 8 is as follows:
1H NMR(400MHz,CDCl3)δ7.92–7.83(m,1H),7.70–7.62(m,1H),7.54–7.47(m,1H),7.45–7.40(m,1H),5.46(dd,J=7.0,3.5Hz,1H),2.06–1.99(m,1H),1.79–1.70(m,1H),1.48–132(m,4H),0.89(t,J=6.1Hz,3H).13C{1H}NMR(100MHz,CDCl3)δ170.7,150.1,133.9,129.0,126.1,125.6,121.7,81.4,34.4,26.9,22.4,13.9;HRMS(ESI-TOF):([M+H]+)calcd for C10H11O2+:191.1072;found:191.1066。1H NMR (400MHz, CDCl3) δ7.92–7.83(m,1H),7.70–7.62(m,1H),7.54–7.47(m,1H),7.45–7.40(m,1H),5.46(dd,J =7.0,3.5Hz,1H),2.06–1.99(m,1H),1.79–1.70(m,1H),1.48–132(m,4H),0.89(t,J=6.1Hz,3H).13C{ 1H}NMR(100MHz,CDCl3)δ170.7,150.1,133.9,129.0,126.1,125.6,121.7,81.4,34.4,26.9,22.4,13.9; HRMS(ESI-TOF):([M+H]+)calcd for C10H11O2+ :191.1072; found: 191.1066.
由以上实施例可知,本发明提供了一种苯酞类化合物及其制备方法,该本发明所述方法不使用贵金属,反应时间更短,反应条件温和;本发明所述方法以简单易得的N-甲氧基苯甲酰胺为原料,一步合成苯酞类化合物,方法简洁、快速、底物适用性广。As can be seen from the above examples, the present invention provides a phthalide compound and a preparation method thereof, the method of the present invention does not use noble metals, the reaction time is shorter, and the reaction conditions are mild; the method of the present invention is simple and easy to obtain N-methoxybenzamide is used as a raw material to synthesize phthalide compounds in one step, and the method is simple, fast and has wide substrate applicability.
对于本领域技术人员而言,显然本发明不限于上述示范性实施例的细节,而且在不背离本发明的精神或基本特征的情况下,能够以其他的具体形式实现本发明。因此,无论从哪一点来看,均应将实施例看作是示范性的,而且是非限制性的,本发明的范围由所附权利要求而不是上述说明限定,因此旨在将落在权利要求的等同要件的含义和范围内的所有变化囊括在本发明内。不应将权利要求中的任何附图标记视为限制所涉及的权利要求。It will be apparent to those skilled in the art that the invention is not limited to the details of the above-described exemplary embodiments, but that the invention can be embodied in other specific forms without departing from the spirit or essential characteristics of the invention. Accordingly, the embodiments should be regarded in all points of view as exemplary and not restrictive, the scope of the invention being defined by the appended claims rather than the foregoing description, and it is therefore intended that the scope of the invention be defined by the appended claims rather than by the foregoing description. All changes within the meaning and range of equivalents of the elements are embraced in the present invention. Any reference sign in a claim should not be construed as limiting the claim concerned.
此外,应当理解,虽然本说明书按照实施方式加以描述,但并非每个实施方式仅包含一个独立的技术方案,说明书的这种叙述方式仅仅是为清楚起见,本领域技术人员应当将说明书作为一个整体,各实施例中的技术方案也可以经适当组合,形成本领域技术人员可以理解的其他实施方式。In addition, it should be understood that although this specification is described according to implementation modes, not each implementation mode only includes an independent technical solution, and this description in the specification is only for clarity, and those skilled in the art should take the specification as a whole , the technical solutions in the various embodiments can also be properly combined to form other implementations that can be understood by those skilled in the art.
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210950641.8A CN115260136B (en) | 2022-08-09 | 2022-08-09 | Phthalide compound and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210950641.8A CN115260136B (en) | 2022-08-09 | 2022-08-09 | Phthalide compound and preparation method thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN115260136A CN115260136A (en) | 2022-11-01 |
CN115260136B true CN115260136B (en) | 2023-08-15 |
Family
ID=83751775
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202210950641.8A Active CN115260136B (en) | 2022-08-09 | 2022-08-09 | Phthalide compound and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN115260136B (en) |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1333764A (en) * | 1998-12-04 | 2002-01-30 | 武田药品工业株式会社 | Benzofuran derivatives, process for the preparation of the same and uses thereof |
JP2002161088A (en) * | 1998-12-04 | 2002-06-04 | Takeda Chem Ind Ltd | Benzofuran derivative, method for producing the same and application thereof |
CN103965147A (en) * | 2009-03-10 | 2014-08-06 | 武田药品工业株式会社 | Benzofuran derivatives |
CN104829565A (en) * | 2015-05-11 | 2015-08-12 | 华东师范大学 | Furanone derivative and synthetic method thereof |
CN108912076A (en) * | 2018-08-31 | 2018-11-30 | 信阳师范学院 | A kind of synthetic method of benzo oxygen helerocyclics |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9073887B2 (en) * | 2011-11-18 | 2015-07-07 | Council Of Scientific & Industrial Research | Single step enantioselective process for the preparation of 3-substituted chiral phthalides |
-
2022
- 2022-08-09 CN CN202210950641.8A patent/CN115260136B/en active Active
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1333764A (en) * | 1998-12-04 | 2002-01-30 | 武田药品工业株式会社 | Benzofuran derivatives, process for the preparation of the same and uses thereof |
JP2002161088A (en) * | 1998-12-04 | 2002-06-04 | Takeda Chem Ind Ltd | Benzofuran derivative, method for producing the same and application thereof |
CN103965147A (en) * | 2009-03-10 | 2014-08-06 | 武田药品工业株式会社 | Benzofuran derivatives |
CN104829565A (en) * | 2015-05-11 | 2015-08-12 | 华东师范大学 | Furanone derivative and synthetic method thereof |
CN108912076A (en) * | 2018-08-31 | 2018-11-30 | 信阳师范学院 | A kind of synthetic method of benzo oxygen helerocyclics |
Non-Patent Citations (1)
Title |
---|
Ligand-Enabled Pd(II)-Catalyzed C(sp3)-H Lactonization Using Molecular Oxygen as Oxidant;Shaoqun Qian等;Org.Lett.(第22期);3960-3963 * |
Also Published As
Publication number | Publication date |
---|---|
CN115260136A (en) | 2022-11-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN114437103B (en) | A method for synthesizing chiral tetrahydrobenzoxazepines through gold-catalyzed asymmetric cycloaddition | |
CN115260136B (en) | Phthalide compound and preparation method thereof | |
CN109879792B (en) | A kind of polysubstituted isoindole compound and preparation method thereof | |
CN110183443B (en) | Synthesis method of indolo [3,2-c ] quinoline compound | |
Kumar et al. | Mn-mediated oxidative radical cyclization of 2-(azidomethyl) phenyl isocyanides with carbazate: Access to quinazoline-2-carboxylates | |
CN114436918B (en) | Cyclobut-1-enamine compound and its preparation method and application in medicine | |
CN115385877B (en) | Dihydrofuran-2-one compound and preparation method thereof | |
CN115093369A (en) | A kind of synthetic method of 3,4-dihydroisoquinoline-1-one compounds | |
CN110724080B (en) | Synthetic method of aryl selenium cyanogen compound | |
CN109734667B (en) | A kind of polysubstituted imidazole compound and its synthetic method and application | |
CN109305970B (en) | Preparation and application of 1, 7-disubstituted aminomethyl-2, 8-dihydroxy-Tr ger's Base catalyst | |
CN106588926B (en) | A kind of 2,7- diazas [3,2,1] bicyclooctane and its derivative and its synthetic method and application | |
CN112480124A (en) | Trifluoromethyl substituted chiral tetrahydropyrrole [1,2-c ] quinazoline-3, 5-diketone and preparation method thereof | |
CN114591331A (en) | Triazole derivative and application thereof in anti-cancer drugs | |
CN114181182B (en) | Synthesis method of polysubstituted 4H-pyran compound | |
CN114516880B (en) | A method for synthesizing furo[2,3-b]quinoxaline derivatives | |
CN119143707B (en) | Spiral-2 (3H) -furanone molecule and preparation method and application thereof | |
CN113234083B (en) | Tetrahydroquinoline pyran compound and preparation method and application thereof | |
Wang et al. | Efficient synthesis of aza-phenanthroindolizidine and aza-phenanthroquinolizidine and anticancer activities | |
CN114213254B (en) | Beta-nitroketone and preparation method and application method thereof | |
CN109020799B (en) | Difluoro dihydroxy naphthalene diketone compound, preparation method and application | |
CN116425717B (en) | C2-site indoline derivative containing quaternary carbon center as well as preparation method and application thereof | |
CN108912127A (en) | A kind of benzo [b, e] azatropylidene compound and preparation method thereof based on isatin skeleton | |
CN116655641A (en) | Tryptamine ketimine compound and derivative thereof, and synthetic method and application thereof | |
CN107383018A (en) | Dihydro pyrazine simultaneously [2,3 b] indoles, pyrazine simultaneously [2,3 b] Benzazole compounds and synthetic method and application |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CP03 | Change of name, title or address | ||
CP03 | Change of name, title or address |
Address after: 314000 No. 899, guangqiong Road, Nanhu District, Jiaxing City, Zhejiang Province Patentee after: Jiaxing University Country or region after: China Address before: No. 899 Guangqiong Road, Nanhu District, Jiaxing City, Zhejiang Province Patentee before: JIAXING University Country or region before: China |